The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Prevalence and Burden of Breathlessness in Patients with Chronic Obstructive Pulmonary Disease Managed in Primary Care
Open accessAbstract
BACKGROUND & AIMS: Breathlessness is a primary clinical feature of chronic obstructive pulmonary disease (COPD). We aimed to describe the frequency of and factors associated with breathlessness in a cohort of COPD patients identified from the Clinical Practice Research Datalink (CPRD), a general practice electronic medical records database. METHODS: Patients with a record of COPD diagnosis after January 1 2008 were identified in the CPRD. Breathlessness was assessed using the Medical Research Council (MRC) dyspnoea scale, with scoring ranging from 1-5, which has been routinely administered as a part of the regular assessment of patients with COPD in the general practice since April 2009. Stepwise multivariate logistic regression estimated independent associations with dyspnoea. Negative binomial regression evaluated a relationship between breathlessness and exacerbation rate during follow-up. RESULTS: The total cohort comprised 49,438 patients diagnosed with COPD; 40,425 (82%) had any MRC dyspnoea grade recorded. Of those, 22,770 (46%) had moderate-to-severe dyspnoea (MRC ≥ 3). Breathlessness increased with increasing airflow limitation; however, moderate-to-severe dyspnoea was also observed in 32% of patients with mild airflow obstruction. Other factors associated with increased dyspnoea grade included female gender, older age (≥ 70 years), obesity (BMI ≥ 30), history of moderate-to-severe COPD exacerbations, and frequent visits to the general practitioner. Patients with worse breathlessness were at higher risk of COPD exacerbations during follow-up. CONCLUSIONS: Moderate-to-severe dyspnoea was reported by >40% of patients diagnosed with COPD in primary care. Presence of dyspnoea, including even a perception of mild dyspnoea (MRC = 2), was associated with increased disease severity and a higher risk of COPD exacerbations during follow-up.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Refractory breathlessness is a highly prevalent and distressing symptom in advanced chronic respiratory disease.”
From The Breathing, Thinking, Functioning clinical model: a proposal to facilitate evidence-based breathlessness management in chronic respiratory disease (2017) · cites this paper as [2]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Its intensity is not reliably predicted by the severity of lung pathology”
From The Breathing, Thinking, Functioning clinical model: a proposal to facilitate evidence-based breathlessness management in chronic respiratory disease (2017) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Global Initiative for Chronic Obstructive Lung Disease
Gerald, L. B., & Bailey, W. C. (2002) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-200207000-00004 · Cited by 5,806
Rabe, K. F., Hurd, S., Anzueto, A., Barnes, P. J., Buist, S. A., Calverley, P., Fukuchi, Y., Jenkins, C., Rodriguez-Roisin, R., van Weel, C., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200703-456so · Cited by 4,925
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
Hurst, J. R., Vestbo, J., Anzueto, A. R., Locantore, N., Müllerová, H., Tal‐Singer, R., Miller, B. E., Lomas, D. A., Agustí, A. G. N., MacNee, W., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909883 · Cited by 2,983
Self-citationBestall, J. C., Paul, E. A., Garrod, R., Garnham, R., Jones, P. W., & Wedzicha, J. A. (1999) · Thorax · doi:10.1136/thx.54.7.581 · Cited by 2,927
Chronic Obstructive Pulmonary Disease
Flavin, K., Morkane, C. M., & Marsh, S. (2018) · Cambridge University Press eBooks · doi:10.1017/9781108233712.025 · Cited by 2,687
Donaldson, G. C. (2002) · Thorax · doi:10.1136/thorax.57.10.847 · Cited by 2,268
Parshall, M. B., Schwartzstein, R. M., Adams, L., Banzett, R. B., Manning, H. L., Bourbeau, J., Calverley, P. M., Gift, A. G., Harver, A., Lareau, S. C., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201111-2042st · Cited by 1,844
Dynamic Hyperinflation and Exercise Intolerance in Chronic Obstructive Pulmonary Disease
O'DONNELL, D. E., REVILL, S. M., & WEBB, K. A. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.5.2012122 · Cited by 1,076
Significance of Respiratory Symptoms and the Diagnosis of Chronic Bronchitis in a Working Population
Fletcher, C. M., Elmes, P. C., Fairbairn, A. S., & Wood, C. H. (1959) · BMJ · doi:10.1136/bmj.2.5147.257 · Cited by 973
Cited by
Sorted by citations
Symptoms and the body: taking the inferential leap
Van den Bergh, O., Witthöft, M., Petersen, S., & Brown, R. J. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.01.015 · Cited by 543
Spathis, A., Booth, S., Moffat, C., Hurst, R., Ryan, R., Chin, C., & Burkin, J. (2017) · npj Primary Care Respiratory Medicine · doi:10.1038/s41533-017-0024-z · Cited by 226
“8 An observational study of almost 50,000 patients with COPD in the UK revealed that a third of those with stage 1 disease described moderate to severe breathlessness, whereas over 20% of those with stage 4 disease did not have clinically significant breathlessness.(2) In a recent controlled trial, bronchoscopic lung…”
BackgroundMaddocks, M. M., Lovell, N., Booth, S., Man, W. D., & Higginson, I. J. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32127-x · Cited by 238
Hanania, N. A., & O’Donnell, D. E. (2019) · International Journal of COPD · doi:10.2147/copd.s188141 · Cited by 156
Wang, S. V., Sreedhara, S. K., Schneeweiß, S., Initiative, R., Franklin, J. M., Gagne, J. J., Huybrechts, K. F., Patorno, E., Jin, Y., Lee, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32310-3 · Cited by 126
Physical activity and chronic obstructive pulmonary disease: a scoping review
Xiang, X., Huang, L., Fang, Y., Cai, S., & Zhang, M. (2022) · BMC Pulmonary Medicine · doi:10.1186/s12890-022-02099-4 · Cited by 115
Ban, L., Sprigg, N., Sultan, A. A., Nelson‐Piercy, C., Bath, P. M., Ludvigsson, J. F., Stephansson, O., & Tata, L. J. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.004601 · Cited by 87
Beeh, K. M., Burgel, P., Franssen, F. M. E., López-Campos, J. L., Loukides, S., Hurst, J. R., Fležar, M., Ulrik, C. S., Marco, F. D., Stolz, D., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201609-1794ci · Cited by 84
Abdallah, S. J., Wilkinson-Maitland, C. A., Saad, N., Li, P. Z., Smith, B. M., Bourbeau, J., & Jensen, D. (2017) · European Respiratory Journal · doi:10.1183/13993003.01235-2017 · Cited by 78
Bourbeau, J., Bhutani, M., Hernandez, P., Aaron, S. D., Balter, M. S., Beauchesne, M.-F., D’Urzo, A. D., Goldstein, R. S., Kaplan, A. G., Maltais, F., et al. (2019) · Canadian Journal of Respiratory Critical Care and Sleep Medicine · doi:10.1080/24745332.2019.1668652 · Cited by 81
Selman, L. E., McDermott, K. A., Donesky, D., Citron, T., & Howie‐Esquivel, J. (2015) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-015-0540-8 · Cited by 80
Landis, S., Suruki, R., Hilton, E., Compton, C. H., & Galwey, N. W. (2017) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412555.2017.1313827 · Cited by 70
Poulos, L. M., Ampon, R. D., Currow, D. C., Marks, G. B., Toelle, B. G., & Reddel, H. K. (2021) · Respirology · doi:10.1111/resp.14070 · Cited by 65
Hollingworth, K., Davis, K. J., Landis, S., Oh, Y., Mannino, D. M., Han, M. K., van der Molen, T., Айсанов, З. Р., Menezes, A. M. B., Ichinose, M., et al. (2014) · International Journal of COPD · doi:10.2147/copd.s70162 · Cited by 64
Self-citationChen, Y., Camp, P. G., Coxson, H. O., ROAD, J. D., Guenette, J. A., Hunt, M. A., & Reid, W. D. (2017) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412555.2017.1401990 · Cited by 60
Sandberg, J., Ekström, M. P., Börjesson, M., Bergström, G. M. L., Rosengren, A., Angerås, O., & Torén, K. (2020) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2020-000643 · Cited by 58
Treatment of severe stable COPD: the multidimensional approach of treatable traits
van Dijk, M., Gan, C. T., Koster, T. D., Wijkstra, P. J., Slebos, D., Kerstjens, H. A. M., van der Vaart, H., & Duiverman, M. L. (2020) · ERJ Open Research · doi:10.1183/23120541.00322-2019 · Cited by 55
Persistent disabling breathlessness in chronic obstructive pulmonary disease
Sundh, J., & Ekström, M. P. (2016) · International Journal of COPD · doi:10.2147/copd.s119992 · Cited by 55
Abdallah, S. J., Smith, B. M., Ware, M. A., Moore, M., Li, P. Z., Bourbeau, J., & Jensen, D. (2018) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201803-198oc · Cited by 52
Prescription of opioids for breathlessness in end-stage COPD: a national population-based study
Ahmadi, Z., Bernelid, E., Currow, D. C., & Ekström, M. P. (2016) · International Journal of COPD · doi:10.2147/copd.s112484 · Cited by 49
How to Assess Breathlessness in Chronic Obstructive Pulmonary Disease
Lewthwaite, H., Jensen, D., & Ekström, M. P. (2021) · International Journal of COPD · doi:10.2147/copd.s277523 · Cited by 49
Raluy-Callado, M., Lambrelli, D., MacLachlan, S., & Khalid, J. M. (2015) · International Journal of COPD · doi:10.2147/copd.s82064 · Cited by 44
Prevalence and management of chronic breathlessness in COPD in a tertiary care center
Carette, H., Zysman, M., Morélot‐Panzini, C., Perrin, J., Gómez, E. M., Guillaumot, A., Burgel, P., Deslée, G., Surpas, P., Rouzic, O. L., et al. (2019) · BMC Pulmonary Medicine · doi:10.1186/s12890-019-0851-5 · Cited by 47
Lewis, A. P., Philip, K. E. J., Lound, A., Cave, P., Russell, J., & Hopkinson, N. S. (2021) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2021-000996 · Cited by 48
Should we measure dyspnoea in everyone?
Banzett, R. B., & O’Donnell, C. R. (2014) · European Respiratory Journal · doi:10.1183/09031936.00031114 · Cited by 42
Landis, S., Suruki, R., Maskell, J., Bonar, K., Hilton, E., & Compton, C. H. (2018) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412555.2018.1441275 · Cited by 41
Finch, D., Jones, P., Watz, H., Wouters, E. F. �., & Cazzola, M. (2016) · International Journal of COPD · doi:10.2147/copd.s85977 · Cited by 38
Pezzuto, A., Stellato, M., Catania, G., Mazzara, C., Tonini, S., Caricato, M., Crucitti, P., & Tonini, G. (2018) · Journal of Breath Research · doi:10.1088/1752-7163/aad0a8 · Cited by 37
Smallwood, N., Currow, D. C., Booth, S., Spathis, A., Irving, L. B., & Philip, J. A. M. (2018) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412555.2018.1502264 · Cited by 34
Punekar, Y. S., Müllerová, H., Small, M., Holbrook, T., Wood, R. P., Naya, I. P., & Valle, M. (2016) · Pulmonary Therapy · doi:10.1007/s41030-016-0011-5 · Cited by 29
Self-citationElliott-Button, H. L., Johnson, M. J., Nwulu, U., & Clark, J. (2019) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2019.10.014 · Cited by 27
GOLD assessment of COPD severity in the Clinical Practice Research Datalink (CPRD)
Rebordosa, C., Plana, E., Aguado, J., Thomas, S., García-Gil, E., Perez‐Gutthann, S., & Castellsagué, J. (2018) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4448 · Cited by 26
Hollingworth, K., Müllerová, H., Landis, S., Айсанов, З. Р., Davis, K. J., Ichinose, M., Mannino, D. M., Maskell, J., Menezes, A. M. B., van der Molen, T., et al. (2016) · International Journal of COPD · doi:10.2147/copd.s102280 · Cited by 26
Self-citationSpathis, A., Burkin, J., Moffat, C., Tuffnell, R., Barclay, S. I. G., Mant, J., & Booth, S. (2021) · npj Primary Care Respiratory Medicine · doi:10.1038/s41533-021-00237-9 · Cited by 24
What have we learned from observational studies and clinical trials of mild to moderate COPD?
Barrecheguren, M., González, C., & Miravitlles, M. (2018) · Respiratory Research · doi:10.1186/s12931-018-0882-0 · Cited by 24
Ding, B., Small, M., & Holmgren, U. (2017) · International Journal of COPD · doi:10.2147/copd.s133793 · Cited by 23
Siraj, R. A., McKeever, T. M., Gibson, J., & Bolton, C. E. (2021) · Respiratory Medicine · doi:10.1016/j.rmed.2022.106804 · Cited by 22
Brain Activations to Dyspnea in Patients With COPD
Reijnders, T., Troosters, T., Janssens, W., Gosselink, R., Langer, D., Davenport, P. W., & von Leupoldt, A. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00007 · Cited by 22
Cherian, M. M., Jensen, D., Tan, W. C., Mursleen, S., Goodall, E. C., Nadeau, G. A., Awan, A. M., Marciniuk, D. D., Walker, B., Aaron, S. D., et al. (2021) · ERJ Open Research · doi:10.1183/23120541.00960-2020 · Cited by 22
Jones, P., Leidy, N. K., Hareendran, A., Lamarca, R., Chuecos, F., & Gil, E. G. (2016) · Respiratory Research · doi:10.1186/s12931-016-0372-1 · Cited by 20
The occurrence mechanism, assessment, and non-pharmacological treatment of dyspnea
Gao, B., Wang, S., & Jiang, S. (2024) · Medical Review · doi:10.1515/mr-2024-0006 · Cited by 21
Waskiw‐Ford, M., Wu, A., Mainra, A., Marchand, N. H., Alhuzaim, A., Bourbeau, J., Smith, B. M., & Jensen, D. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00086 · Cited by 16
Jensen, D., Schaeffer, M. R., & Guenette, J. A. (2018) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0000000000000377 · Cited by 16
Sharma, P. K., & Sharma, S. (2019) · Indian Journal of Respiratory Care · doi:10.4103/ijrc.ijrc_21_18 · Cited by 15
Impact of baseline symptoms and health status on COPD exacerbations in the FLAME study
Mackay, A. J., Κostikas, Κ., Roche, N., Frent, S., Olsson, P., Pfister, P., Gupta, P., Patalano, F., Banerji, D. D., & Wedzicha, J. A. (2020) · Respiratory Research · doi:10.1186/s12931-020-01354-8 · Cited by 16
Williams, M., Lewthwaite, H., Paquet, C., Cafarella, P., & Frith, P. A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12237286 · Cited by 16
Maltais, F., de la Hoz, A., Casaburi, R. H., & O'Donnell, D. E. (2020) · Advances in Therapy · doi:10.1007/s12325-020-01557-x · Cited by 15
Politis, J., Eastman, P., Le, B. H. C., Furler, J., Irving, L. B., & Smallwood, N. (2020) · American Journal of Hospice and Palliative Medicine® · doi:10.1177/1049909120959061 · Cited by 14
Daynes, E., Greening, N. J., & Singh, S. J. (2021) · Thorax · doi:10.1136/thoraxjnl-2021-217072 · Cited by 14
de, M. M., Aguirre, C., Varela, M. V. L., Laucho-Contreras, M. E., Casas, A., & Surmont, F. (2016) · International Journal of COPD · doi:10.2147/copd.s120776 · Cited by 14
Athanazio, R. A., Villada, L. B., Avdeev, S. N., Wang, H., Ramírez‐Venegas, A., Sívori, M., Dreyse, J., Pacheco, M., Sin, K. M., Noriega, L., et al. (2024) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2023-002101 · Cited by 14
The lived experience of refractory breathlessness for people living in the community
Tieck, K., Mackenzie, L. A., & Lovell, M. R. (2018) · British Journal of Occupational Therapy · doi:10.1177/0308022618804754 · Cited by 13
Recommendations for COPD management in Central and Eastern Europe
Valipour, A., Айсанов, З. Р., Avdeev, S. N., Koblížek, V., Kocan, I., Kopitović, I., Lupkovics, G., Man, M. A., Bukovskis, M., Tudorić, N., et al. (2022) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2021.2023498 · Cited by 13
Research and Healthcare Priorities of Individuals Living with COPD
Michalovic, E., Sweet, S. N., & Jensen, D. (2021) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412555.2021.1901271 · Cited by 12
Current Approaches for Phenotyping as a Target for Precision Medicine in COPD Management
López-Campos, J. L., & Centanni, S. (2018) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412555.2018.1443064 · Cited by 12
Understanding Breathlessness Burden and Psychophysiological Correlates in Asthma
Lewthwaite, H., Gibson, P. G., Guerrero, P. D. U., Smith, A., Clark, V. L., Vertigan, A. E., Hiles, S. A., Bailey, B. L., Yorke, J., & McDonald, V. M. (2024) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2024.06.019 · Cited by 11
Breathlessness without borders: a call to action for global breathlessness research
Clark, J., Binnie, K., Bond, M., Crooks, M. G., Currow, D. C., Curry, J., Elsey, H., Habib, G. M., Hutchinson, A., Soyiri, I. N., et al. (2024) · npj Primary Care Respiratory Medicine · doi:10.1038/s41533-024-00384-9 · Cited by 11
Mooren, K., Smit, K., Engels, Y., Janssen, D. J. A., & Godschalx-Dekker, J. (2022) · BMC Pulmonary Medicine · doi:10.1186/s12890-022-02250-1 · Cited by 11
Beaumont, M., Garrec, M. L., Péran, L., Berriet, A., Ber, C. L., Pichon, R., & Cabillic, M. (2020) · The Clinical Respiratory Journal · doi:10.1111/crj.13318 · Cited by 11
Vézina, F.-A., Bouchard, P., Breton-Gagnon, É., Dion, G., Viglino, D., Roy, P., Bilodeau, L., Provencher, S., Denault, M., Saey, D., et al. (2023) · Respiratory care · doi:10.4187/respcare.10810 · Cited by 8
Time to diagnosis and long-term outcomes for adults presenting with breathlessness
Karsanji, U., Lawson, C. A., Petherick, E., Khunti, K. K., Doe, G. E., Quint, J. K., Bottle, A., STEINER, M. C., & Evans, R. A. (2025) · Thorax · doi:10.1136/thorax-2024-222795 · Cited by 10
Benson, V. S., Pascoe, K. C., Siddall, J., Small, M., & Müllerová, H. (2019) · International Journal of COPD · doi:10.2147/copd.s217503 · Cited by 10
Self-citationNasal High Flow Therapy For Symptom Management in People Receiving Palliative Care
Huang, J. Y., Steele, P., Dabscheck, E. J., & Smallwood, N. (2021) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2021.09.016 · Cited by 10
Prevalence of dyspnea after stroke: a telephone-based survey
de Menezes, K. K. P., Nascimento, L. R., Alvarenga, M. T. M., Avelino, P. R., & Teixeira‐Salmela, L. F. (2018) · Brazilian Journal of Physical Therapy · doi:10.1016/j.bjpt.2018.09.006 · Cited by 9
Denton, E. J., Bondarenko, J., & Hew, M. J. (2022) · European Respiratory Society eBooks · doi:10.1183/2312508x.10013221 · Cited by 9
Tawara, Y., Senjyu, H., Tanaka, K., Tanaka, T. I., Asai, M., Kozu, R., Tabusadani, M., Honda, S., & Sawai, T. (2015) · International Journal of COPD · doi:10.2147/copd.s82872 · Cited by 9
Hudson, A. L., Day, M.-E., Williams, M., & Harrison, O. K. (2025) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2025.104441 · Cited by 10
Pooled Cohort Probability Score for Subclinical Airflow Obstruction
Bhatt, S. P., Balte, P. P., Schwartz, J. E., Jaeger, B. C., Cassano, P. A., Chaves, P. H. M., Couper, D. J., Jacobs, D. R., Kalhan, R., Kaplan, R. C., et al. (2022) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202109-1020oc · Cited by 8
Witusik, A., Mokros, Ł., Kuna, P., Nowakowska‐Domagała, K., Antczak, A. J., & Pietras, T. (2018) · Medical Science Monitor · doi:10.12659/msm.907742 · Cited by 8
Mountain, R., Kim, D., & JOHNSON, K. (2023) · CMAJ Open · doi:10.9778/cmajo.20230023 · Cited by 7
Association of Symptoms of Obstructive Lung Disease and All‐Cause Mortality in Older Adult Smokers
Opina, M. T. D., Nicklas, B. J., Lovato, J. F., Files, D. C., Kritchevsky, S. B., & Moore, W. C. (2019) · Journal of the American Geriatrics Society · doi:10.1111/jgs.16052 · Cited by 7
Vaezi, A., & Mirsaeidi, M. S. (2024) · Medicine · doi:10.1097/md.0000000000037715 · Cited by 6
Spathis, A., Reilly, C. C., Bausewein, C., Reinke, L. F., Romero, L., Smallwood, N., Ekström, M. P., & Holland, A. E. (2024) · European Respiratory Review · doi:10.1183/16000617.0054-2024 · Cited by 6
Chen, X. E., Moran, T. J., & Smallwood, N. (2022) · Internal Medicine Journal · doi:10.1111/imj.15770 · Cited by 6
Putcha, N., Maselli, D. J., Bon, J. M., Lester, M., & Drummond, M. (2025) · Pulmonary Therapy · doi:10.1007/s41030-025-00318-x · Cited by 6
Avdeev, S. N., Викторович, Л. И., Ignatova, G. V., Николаевич, А. В., Kostina, N. E., Кочегарова, Е. Ю., Иванович, А. А., Трушенко, Н. В., Chikina, S. Y., Nuralieva, G. S., et al. (2024) · PULMONOLOGIYA · doi:10.18093/0869-0189-2024-34-3-427-440 · Cited by 5
Brunton, S., & Hogarth, D. K. (2023) · Postgraduate Medicine · doi:10.1080/00325481.2023.2284650 · Cited by 5
Guay, C.-A., Maltais, F., Beaudoin, C., Carmichael, P., Sidi, E. A. L., Perreault, L., Sirois, C., & Provencher, S. (2024) · BMC Pulmonary Medicine · doi:10.1186/s12890-024-03277-2 · Cited by 5
Park, J., Lee, J. S., Rhee, C. K., & Oh, Y. (2015) · Journal of Korean Medical Science · doi:10.3346/jkms.2015.30.10.1453 · Cited by 5
Evaluating dyspnoea in chronic obstructive pulmonary disease
Ong, K.-C. (2021) · Precision and Future Medicine · doi:10.23838/pfm.2020.00212 · Cited by 5
The management of chronic breathlessness
Evans, R. A., Spathis, A., Daynes, E., & Currow, D. C. (2022) · European Respiratory Society eBooks · doi:10.1183/2312508x.10013921 · Cited by 5
Singh, D., Bafadhel, M., Arya, N., Marshall, J., Parikh, H., Kisielewicz, D., Movitz, C., Bowen, K., & Patel, M. (2025) · Respiratory Research · doi:10.1186/s12931-025-03234-5 · Cited by 4
Sinonasal Symptoms in COPD: Burden and Associations with Clinical Markers of Disease
Øie, M. R., Helvik, A., Sue‐Chu, M., Steinsvåg, S., & Thorstensen, W. M. (2022) · International Journal of COPD · doi:10.2147/copd.s372991 · Cited by 4
Schroijen, M., Davenport, P. W., den Bergh, O. V., & Diest, I. V. (2020) · Wiley eBooks · doi:10.1002/9781118597309.ch22 · Cited by 3
The prevalence of dyspnea in the adult Polish population
Undrunas, A., Bandosz, P., Rutkowski, M., Puch-Walczak, A., Kuziemski, K., & Zdrojewski, T. R. (2022) · International Journal of Occupational Medicine and Environmental Health · doi:10.13075/ijomeh.1896.01959 · Cited by 3
Vulpi, M. R., Liotino, V., Dragonieri, S., Buonamico, E., Dimitri, M., Capozzolo, A., Resta, E., Lozupone, M., Panza, F., & Resta, O. (2020) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2020.1747437 · Cited by 3
Yadav, R. S., Kant, S., Tripathi, P. M., Pathak, A. K., & Mahdi, A. A. (2021) · Gene Reports · doi:10.1016/j.genrep.2021.101453 · Cited by 3
Should We Consider Screening Spirometry in Individuals Who Are “Asymptomatic”?
Fortis, S. (2022) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202205-374ed · Cited by 3
Ballering, A., Niwa, S., den Bergh, O. V., & Rosmalen, J. G. M. (2025) · Psychosomatic Medicine · doi:10.1097/psy.0000000000001382 · Cited by 2
Radovanovic, D., Signorello, J. C., Fuccia, G., Lazzaroni, G., Danzo, F., Guandalini, G. M., Massaro, F., Tursi, F., & Santus, P. (2025) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2025.04.039 · Cited by 4
Bleazard, L., Walker, K., Ashton, S., & Faull, C. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-112993 · Cited by 2
Rouzic, O. L., Picaud, M., Salvator, H., Bautin, N., Devillier, P., & Perez, T. (2024) · Respiratory Medicine and Research · doi:10.1016/j.resmer.2023.101082 · Cited by 2
Gürbüz, A. K., & Demi̇rel, A. (2024) · Heart & Lung · doi:10.1016/j.hrtlng.2024.06.004 · Cited by 2
Watson, J. S. (2018) · British Journal of Community Nursing · doi:10.12968/bjcn.2018.23.8.376 · Cited by 2
Rohmah, U. N., Amin, M., & Makhfudli, M. (2020) · INDONESIAN NURSING JOURNAL OF EDUCATION AND CLINIC (INJEC) · doi:10.24990/injec.v5i1.291 · Cited by 2
Relevance of multidimensional dyspnea assessment in the context of pulmonary rehabilitation
Molinier, V., Moine, E., Caille, P., Fernandes, N., Alexandre, F., & Héraud, N. (2024) · Chronic Respiratory Disease · doi:10.1177/14799731241255135 · Cited by 3
Obesity and obstructive lung disease: An epidemiologic review
Bhatia, S., & Sood, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813553-2.00004-x · Cited by 2
Pereira, S., Verhille, J., Cailliau, É., Bonniaud, P., Devouassoux, G., Fry, S., Guilleminault, L., Khayath, N., Leroyer, C., Chenivesse, C., et al. (2023) · Clinical & Experimental Allergy · doi:10.1111/cea.14392 · Cited by 1
Family Caregivers and Breathlessness in Individuals with Chronic Obstructive Pulmonary Disease
Sloop, K., Spigelmyer, P. C., Turk, M. T., & Price, K. (2024) · Home Health Care Management & Practice · doi:10.1177/10848223241248178 · Cited by 1
Impact du genre sur les effets de la réadaptation respiratoire chez les patients atteints de BPCO
Ruelland, C., & Beaumont, M. (2024) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2024.06.007 · Cited by 1
Metadata
- Authors
- Müllerová, H., Lu, C., Li, H., & Tabberer, M.
- Affiliations
- GlaxoSmithKline (United Kingdom) (GB)
- GlaxoSmithKline (United States) (US)
- Corresponding author
- Müllerová, Hana
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-01-10
- Volume
- 9
- Issue
- 1
- Pages
- e85540
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3888425
- OpenAlex
- W2062066840
- Cited by
- 139
- References
- 43
- Citations by year
- 2026: 12 · 2025: 12 · 2024: 15 · 2023: 6 · 2022: 17 · 2021: 15 · 2020: 11 · 2019: 9 · 2018: 17 · 2017: 10 · 2016: 9 · 2015: 4 · 2014: 2
- FWCI
- 6.69
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- GlaxoSmithKline
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Keywords
- chronic obstructive pulmonary disease, dyspnea, MRC dyspnoea scale, COPD exacerbations, airflow obstruction, disease severity, obesity, primary care
- MeSH terms
- Aged, Dyspnea, Female, Follow-Up Studies, Humans, Male, Middle Aged, Primary Health Care, Respiratory Function Tests, Risk Factors, Severity of Illness Index, Cohort Studies, Prevalence, Databases, Factual, Pulmonary Disease, Chronic Obstructive, Public Health Surveillance, Patient Outcome Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review